101 related articles for article (PubMed ID: 20920870)
21. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C; Brisson J; Bérubé S; Pollak M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
[TBL] [Abstract][Full Text] [Related]
22. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.
Wong HL; Delellis K; Probst-Hensch N; Koh WP; Van Den Berg D; Lee HP; Yu MC; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):144-51. PubMed ID: 15668488
[TBL] [Abstract][Full Text] [Related]
23. IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion.
Rasat R; Livesey JL; Espiner EA; Abbott GD; Donald RA
N Z Med J; 1996 May; 109(1021):156-9. PubMed ID: 8657365
[TBL] [Abstract][Full Text] [Related]
24. Dinucleotide repeat in the insulin-like growth factor-I gene is not related to risk of colorectal adenoma.
Giovannucci E; Haiman CA; Platz EA; Hankinson SE; Pollak MN; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1509-10. PubMed ID: 12433739
[No Abstract] [Full Text] [Related]
25. The relationship in Japanese infants between a genetic polymorphism in the promoter region of the insulin-like growth factor I gene and the plasma level.
Kinoshita Y; Kizaki Z; Ishihara Y; Nakajima H; Adachi S; Kosaka K; Kinugasa A; Sugimoto T
Neonatology; 2007; 92(2):116-9. PubMed ID: 17377412
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
Wass JA
J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991
[TBL] [Abstract][Full Text] [Related]
28. Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly.
Sneppen SB; Lange M; Pedersen LM; Kristensen L LØ; Main KM; Juul A; Skakkebaek NE; Feldt-Rasmussen U
Growth Horm IGF Res; 2001 Dec; 11(6):384-91. PubMed ID: 11914026
[TBL] [Abstract][Full Text] [Related]
29. Use of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in the diagnosis of acromegaly and growth hormone deficiency in adults.
Thissen JP; Ketelslegers JM; Maiter D
Growth Regul; 1996 Dec; 6(4):222-9. PubMed ID: 8971551
[TBL] [Abstract][Full Text] [Related]
30. Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.
Graziano F; Ruzzo A; Canestrari E; Catalano V; Santini D; Galluccio N; Loupakis F; Alessandroni P; Spada D; Ficarelli R; Bisonni R; D'Emidio S; Vincenzi B; Angeletti S; Salvatore L; Cremolini C; Tonini G; Falcone A; Magnani M
Pharmacogenomics; 2010 Sep; 11(9):1247-56. PubMed ID: 20860465
[TBL] [Abstract][Full Text] [Related]
31. Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly.
Sala E; Filopanti M; Ferrante E; Barbieri AM; Malchiodi E; Verrua E; Giavoli C; Lania AG; Arosio M; Beck-Peccoz P; Spada A; Mantovani G
Eur J Clin Invest; 2014 Dec; 44(12):1222-9. PubMed ID: 25370837
[TBL] [Abstract][Full Text] [Related]
32. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
33. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
Unsal E; Köksal D; Yurdakul AS; Atikcan S; Cinaz P
Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
[TBL] [Abstract][Full Text] [Related]
34. Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.
Minuto F; Resmini E; Boschetti M; Arvigo M; Sormani MP; Giusti M; Ferone D; Barreca A
Clin Endocrinol (Oxf); 2004 Jul; 61(1):138-44. PubMed ID: 15212656
[TBL] [Abstract][Full Text] [Related]
35. Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia.
Bonvicini C; Gennarelli M; Scassellati C; Bignotti S; Gardella R; Barlati S; Valsecchi P; Sacchetti E
Psychiatr Genet; 2010 Feb; 20(1):44-5. PubMed ID: 20010316
[No Abstract] [Full Text] [Related]
36. Association between acromegaly and a single nucleotide polymorphism (rs2854744) in the IGFBP3 gene.
Gao M; Zhu B; Xu Z; Liu S; Liu J; Zhang G; Gao Y; Fan Y; Kang X
BMC Med Genet; 2018 Oct; 19(1):182. PubMed ID: 30290787
[TBL] [Abstract][Full Text] [Related]
37. Association of CA repeat polymorphism at intron 1 of insulin-like growth factor (IGF-I) gene with circulating IGF-I concentration, growth, and fatness in swine.
Estany J; Tor M; Villalba D; Bosch L; Gallardo D; Jiménez N; Altet L; Noguera JL; Reixach J; Amills M; Sánchez A
Physiol Genomics; 2007 Oct; 31(2):236-43. PubMed ID: 17579179
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
[TBL] [Abstract][Full Text] [Related]
39. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly.
Jallad RS; Trarbach EB; Duarte FH; Jorge AA; Bronstein MD
Pituitary; 2015 Oct; 18(5):666-73. PubMed ID: 25552351
[TBL] [Abstract][Full Text] [Related]
40. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study.
Rivadeneira F; Houwing-Duistermaat JJ; Beck TJ; Janssen JA; Hofman A; Pols HA; Van Duijn CM; Uitterlinden AG
J Bone Miner Res; 2004 Aug; 19(8):1280-90. PubMed ID: 15231015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
